Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter.
about
Eat dirt: CpG DNA and immunomodulation of asthmaHepatitis C Virus Stabilizes Hypoxia-Inducible Factor 1 and Stimulates the Synthesis of Vascular Endothelial Growth FactorMyeloid cells in the tumor microenvironment: Role of adenosineSuppression of PLCbeta2 by endotoxin plays a role in the adenosine A(2A) receptor-mediated switch of macrophages from an inflammatory to an angiogenic phenotypeIKK2 inhibition attenuates laser-induced choroidal neovascularizationThe targeting expression of the vascular endothelial growth factor gene in endothelial cells regulated by HRE.ppET-1.A selective small-molecule nuclear factor-kappaB inhibitor from a high-throughput cell-based assay for "activator protein-1 hits".Regulation of inflammatory gene expression in PBMCs by immunostimulatory botanicalsMulti-gene targeted antiangiogenic therapies for experimental corneal neovascularization.Toll-like receptor 4 in inflammation and angiogenesis: a double-edged sword.Macrophages and immunologic inflammation of the kidney.Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappaB/HIF-1alpha activationStretch-induced hypertrophy activates NFkB-mediated VEGF secretion in adult cardiomyocytes.Toll-like receptors, tissue injury, and tumourigenesisPeroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α.Mechanisms of Hypoxic Up-Regulation of Versican Gene Expression in Macrophages.Role of HIF-1 and NF-kappaB transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals.Mechanisms of induction of adenosine receptor genes and its functional significance.Vascular endothelial growth factor ameliorates the ataxic phenotype in a mouse model of spinocerebellar ataxia type 1.Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury.Inhibition of VEGF expression and corneal neovascularization by shRNA targeting HIF-1α in a mouse model of closed eye contact lens wear.Regulation of macrophage function by adenosine.Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors.Regulation of inflammation by adenosine.Macrophage activation by endogenous danger signalsAngiogenesis in rheumatoid arthritis is fostered directly by toll-like receptor 5 ligation and indirectly through interleukin-17 induction.CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complexInhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action.G protein-coupled receptor connectivity to NF-kappaB in inflammation and cancer.Toll-like receptors, wound healing, and carcinogenesis.Role of JunB in adenosine A2B receptor-mediated vascular endothelial growth factor production.Differential regulation of HIF-1alpha isoforms in murine macrophages by TLR4 and adenosine A(2A) receptor agonists.Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth.Microglia in ischemic brain injury.ENTPD1/CD39 is a promising therapeutic target in oncology.Metronomic chemotherapy and anti-angiogenesis: can upgraded pre-clinical assays improve clinical trials aimed at controlling tumor growth?CNS macrophages and peripheral myeloid cells in brain tumours.Induction of murine adenosine A(2A) receptor expression by LPS: analysis of the 5' upstream promoter.Cooperation of adenosine with macrophage Toll-4 receptor agonists leads to increased glycolytic flux through the enhanced expression of PFKFB3 gene.Lack of effect of adenosine on the function of rodent osteoblasts and osteoclasts in vitro.
P2860
Q24648479-11DFEA35-790F-4F7C-8CDC-F8C42580112CQ27481487-9C33B8C6-94E0-4E14-8A83-9AD32ADA2768Q28069621-4F16FB6F-70DB-4690-BC14-6E6698493E2EQ28507352-798566FB-3932-4690-9DD5-96AF82CD84EFQ28539266-386DC1BE-9A87-46CE-8214-4BD3D621ADCCQ33383262-4837950F-9F9A-4D0F-93C9-1A1187FA62C7Q33414478-9262B255-380F-4845-AD5E-B4AC5FE4E82EQ33691344-74710B82-B74E-4971-9B65-3DA3F434CAB6Q33694084-E8A2AE90-BA9D-4D29-A2D9-1AE9BD6552EAQ33851340-094A059F-9793-447E-A6E1-D26B64166F7CQ34067326-78E0BC88-9608-4C41-BE3B-F8A11101461CQ34085964-9DAA4D04-3752-4918-A64A-3DAC401CE3FEQ34103601-39D0A9D1-EEAD-4198-BA7B-3247E96ABB98Q34143804-303629A3-9691-41F7-AB74-083BEB5AA1EAQ34491398-D55D2907-C4F4-4795-A1CB-275B79B9B444Q35658034-227B6C2A-B488-4D84-9277-6D7B6B6BA9D2Q35674550-FD8B5EF9-C96E-42D5-B6EF-27C3CF552B71Q35692398-0C8F4F40-42C0-4601-B94E-7EE357253706Q35779546-FB0F881E-2F97-4B79-8716-D37934EE5A0DQ35780746-D23FAAAB-677E-45CD-8FAA-F80E56F29DFAQ35891550-740FE8CA-96D5-437F-81F4-D43779F8772AQ36070200-57B067C7-6F41-42AF-AA5F-184A3C592F60Q36202827-36861C98-ED5B-4ABC-8322-9FEFBD7D77EAQ36746981-BFA7C036-9F9B-42E9-9569-9355E1C897C5Q37045743-56D80843-9A5B-472B-991A-E9917C265771Q37060590-99226C4D-D47B-4488-9B21-A51A9AC25EDBQ37112245-594A2A00-CA7E-4851-970F-124667104975Q37287000-4E8A0723-15E0-48CA-B066-50335C63BB39Q37293340-CFE852E1-F537-46BA-8392-365E58FCDF09Q37352820-2CEEAAAD-49A1-4481-9CD5-154E81F21383Q37405416-98BE93C0-64E0-44E0-B3BA-4AA7879C4B94Q37486496-92BA9567-B46B-482A-8940-A7097AF338F1Q37540216-61590AF1-E662-4BBB-BE0C-CC61C50983EDQ37733265-B7516E79-654D-4D3C-8F13-DEBB6AB43BCFQ38023121-3AA990B0-67C3-4622-99DB-ED7EACA9AE91Q38155883-F4327F61-F737-46CB-8472-2D5BAC210721Q38203815-AB87F478-A0E3-49E7-B0C1-1B1A745CA9B5Q39208824-44B10BC3-0ECA-4F05-B451-BB70A2A92762Q39564669-76393015-055D-4383-9AF8-726724876A30Q40932223-3B44E39D-70F1-4FE4-967B-176CCC2D4F00
P2860
Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Synergistic up-regulation of v ...... element in the VEGF promoter.
@ast
Synergistic up-regulation of v ...... element in the VEGF promoter.
@en
type
label
Synergistic up-regulation of v ...... element in the VEGF promoter.
@ast
Synergistic up-regulation of v ...... element in the VEGF promoter.
@en
prefLabel
Synergistic up-regulation of v ...... element in the VEGF promoter.
@ast
Synergistic up-regulation of v ...... element in the VEGF promoter.
@en
P2093
P2860
P921
P356
P1476
Synergistic up-regulation of v ...... element in the VEGF promoter.
@en
P2093
Grace Pinhal-Enfield
Madhuri Ramanathan
P2860
P356
10.1091/MBC.E06-07-0596
P577
2006-10-25T00:00:00Z